ROLE OF THE SPANISH AGENCY FOR MEDICINES AND MEDICAL DEVICES (AEMPS) IN THE ASSESSMENT OF CENTRALISED MEDICINAL PRODUCTS

被引：0
|
作者：
Alonso-Gutierrez, A. [1 ]
Sulleiro-Avendano, E. [1 ]
Padilla-Gallego, M. E. [1 ]
Diaz-Ramos, P. [1 ]
机构：
[1] Agencia Espanola Medicamentos & Prod Sanitarios, Madrid, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2011年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [41] The European Medicines Agency Review of Eribulin for the Treatment of Patients with Locally Advanced or Metastatic Breast Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
    Pean, Elias
    Klaar, Sigrid
    Berglund, Eva Gil
    Salmonson, Tomas
    Borregaard, Jeanett
    Hofland, Kenneth F.
    Ersboll, Jens
    Abadie, Eric
    Giuliani, Rosa
    Pignatti, Francesco
    CLINICAL CANCER RESEARCH, 2012, 18 (17) : 4491 - 4497
  • [42] From Lipoproteins to Chondrocytes: A Brief Summary of the European Medicines Agency's Regulatory Guidelines for Advanced Therapy Medicinal Products
    Kassim, Sadik H.
    Somerville, Robert P. T.
    HUMAN GENE THERAPY, 2013, 24 (06) : 568 - 570
  • [43] Commentary on the European Medicines Agency's extended mandate: Protecting public health in times of crisis and improving availability of medicines and medical devices
    Abed, Inga
    Gonzalez-Quevedo, Rosa
    Mura, Manuela
    Dias, Monica
    da Rocha Dias, Silvy
    Garcia Burgos, Juan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 5 - 10
  • [44] Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human Use
    Cilia, Mark
    Ruiz, Sol
    Richardson, Peter
    Salmonson, Tomas
    Serracino-Inglott, Anthony
    Wirth, Francesca
    Borg, John Joseph
    AAPS PHARMSCITECH, 2018, 19 (02): : 489 - 511
  • [45] Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency’s Committee for Medicinal Products for Human Use
    Mark Cilia
    Sol Ruiz
    Peter Richardson
    Tomas Salmonson
    Anthony Serracino-Inglott
    Francesca Wirth
    John Joseph Borg
    AAPS PharmSciTech, 2018, 19 : 489 - 511
  • [46] Regulatory review of the environmental risk assessment of veterinary medicinal products in the European Union, with particular focus on the centralised authorisation procedure
    Julia Fabrega
    Ricardo Carapeto
    Environmental Sciences Europe, 2020, 32
  • [47] Regulatory review of the environmental risk assessment of veterinary medicinal products in the European Union, with particular focus on the centralised authorisation procedure
    Fabrega, Julia
    Carapeto, Ricardo
    ENVIRONMENTAL SCIENCES EUROPE, 2020, 32 (01)
  • [48] The combination of medical devices and medicinal products revisited from the new European legal framework
    Antich-Isern, Pau
    Caro-Barri, Julia
    Aparicio-Blanco, Juan
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 607
  • [49] Integrated Safety and Risk Assessment for Medical Devices and Combination Products
    Traul, Karl A.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2020, 39 (04) : 354 - 355
  • [50] Residual Isocyanates in Medical Devices and Products: A Qualitative and Quantitative Assessment
    Franklin, Gillian
    Harari, Homero
    Ahsan, Samavi
    Bello, Dhimiter
    Sterling, David A.
    Nedrelow, Jonathan
    Raynaud, Scott
    Biswas, Swati
    Liu, Youcheng
    ENVIRONMENTAL HEALTH INSIGHTS, 2016, 10 : 175 - 190
12345